View in EDS

Serum Vascular Endothelial Growth Factor Predicts Venous Invasion in Hepatocellular Carcinoma : A Prospective Study

Saved in:
Bibliographic Details
Title: Serum Vascular Endothelial Growth Factor Predicts Venous Invasion in Hepatocellular Carcinoma : A Prospective Study
Authors: Zhu, LX, Yu, WC, Lau, C, Poon, RTP, Ng, IOL, Lo, CM, Fan, ST, Wong, J
Source: Annals of Surgery. 233:227-235
Publisher Information: Ovid Technologies (Wolters Kluwer Health), 2001.
Publication Year: 2001
Subject Terms: Adult, Male, Vascular Endothelial Growth Factor A, Carcinoma, Hepatocellular, Endothelial Growth Factors - blood, Hepatocellular - blood - blood supply - pathology, Endothelial Growth Factors, Lymphokines - blood, 03 medical and health sciences, 0302 clinical medicine, Humans, Neoplasm Invasiveness, Prospective Studies, Neovascularization, Aged, Pathologic, Lymphokines, Neovascularization, Pathologic, Platelet Count, Vascular Endothelial Growth Factors, Carcinoma, Liver Neoplasms, Liver Neoplasms - blood - blood supply - pathology, Middle Aged, Immunohistochemistry, 3. Good health, Carcinoma, Hepatocellular - blood - blood supply - pathology, Female
Description: To evaluate the correlation between serum vascular endothelial growth factor (VEGF) level and the clinicopathologic features in patients with hepatocellular carcinoma (HCC).VEGF is an important angiogenic factor regulating tumor angiogenesis. A high serum VEGF level has been shown to be associated with tumor progression and metastasis in several human cancers, but its significance in HCC is unclear. The correlation between serum VEGF level and tumor pathologic features in patients with HCC has not been studied before.Preoperative serum samples and tumor specimens were prospectively collected in 100 patients undergoing resection of HCC. Serum VEGF level was measured by enzyme-linked immunosorbent assay, and tumor VEGF expression was assessed by immunohistochemical study. Histopathologic examination was performed by a pathologist without prior knowledge of the serum VEGF level or tumor VEGF expression.Preoperative serum VEGF levels ranged from 15 to 1,789 pg/mL (median 269). When serum VEGF levels were compared between groups categorized by different clinicopathologic variables, significant correlation was found between a high serum VEGF level and absence of tumor capsule, presence of intrahepatic metastasis, presence of microscopic venous invasion, and advanced stage. There was a positive correlation between the serum VEGF level and tumor expression of VEGF as well as platelet count. When the 75th percentile serum VEGF level (500 pg/mL) was used as a cutoff level, the frequency of venous invasion in patients with a high serum VEGF level was significantly greater compared with patients with a low serum VEGF level. By multivariate analysis, a serum VEGF level of more than 500 pg/mL and tumor size more than 5 cm were independent preoperative factors predictive of microscopic venous invasion. During a median follow-up of 11.6 months, 48% of patients with a serum VEGF level of more than 500 pg/mL and 27% of those with a serum VEGF level of 500 pg/mL or less developed postoperative recurrence.These results show that a high preoperative serum VEGF level is a predictor of microscopic venous invasion in HCC, suggesting that the serum VEGF level may be useful as a biologic marker of tumor invasiveness and a prognostic factor in HCC.
Document Type: Article
Conference object
Language: English
ISSN: 0003-4932
DOI: 10.1097/00000658-200102000-00012
Access URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1421205
https://pubmed.ncbi.nlm.nih.gov/11176129
https://europepmc.org/article/MED/11176129
https://core.ac.uk/display/37912673
http://journals.lww.com/00000658-200102000-00012
https://pubmed.ncbi.nlm.nih.gov/11176129/
https://hub.hku.hk/handle/10722/83280
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1421205/
http://hdl.handle.net/10722/104879
http://hdl.handle.net/10722/83280
Accession Number: edsair.doi.dedup.....c34e42e051c14084e2dfcb328d2a8bd3
Database: OpenAIRE
Description
Abstract:To evaluate the correlation between serum vascular endothelial growth factor (VEGF) level and the clinicopathologic features in patients with hepatocellular carcinoma (HCC).VEGF is an important angiogenic factor regulating tumor angiogenesis. A high serum VEGF level has been shown to be associated with tumor progression and metastasis in several human cancers, but its significance in HCC is unclear. The correlation between serum VEGF level and tumor pathologic features in patients with HCC has not been studied before.Preoperative serum samples and tumor specimens were prospectively collected in 100 patients undergoing resection of HCC. Serum VEGF level was measured by enzyme-linked immunosorbent assay, and tumor VEGF expression was assessed by immunohistochemical study. Histopathologic examination was performed by a pathologist without prior knowledge of the serum VEGF level or tumor VEGF expression.Preoperative serum VEGF levels ranged from 15 to 1,789 pg/mL (median 269). When serum VEGF levels were compared between groups categorized by different clinicopathologic variables, significant correlation was found between a high serum VEGF level and absence of tumor capsule, presence of intrahepatic metastasis, presence of microscopic venous invasion, and advanced stage. There was a positive correlation between the serum VEGF level and tumor expression of VEGF as well as platelet count. When the 75th percentile serum VEGF level (500 pg/mL) was used as a cutoff level, the frequency of venous invasion in patients with a high serum VEGF level was significantly greater compared with patients with a low serum VEGF level. By multivariate analysis, a serum VEGF level of more than 500 pg/mL and tumor size more than 5 cm were independent preoperative factors predictive of microscopic venous invasion. During a median follow-up of 11.6 months, 48% of patients with a serum VEGF level of more than 500 pg/mL and 27% of those with a serum VEGF level of 500 pg/mL or less developed postoperative recurrence.These results show that a high preoperative serum VEGF level is a predictor of microscopic venous invasion in HCC, suggesting that the serum VEGF level may be useful as a biologic marker of tumor invasiveness and a prognostic factor in HCC.
ISSN:00034932
DOI:10.1097/00000658-200102000-00012